37531 |
Oncology |
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first... |
LANCET ONCOL 2020 10.1016/S1470-2045(20)30315-6 |
박세훈 |
2020 |
37530 |
Oncology |
Tislelizumab in Asian patients with previously treated locally advance... |
CANCER SCI 2020 10.1111/cas.14681 |
박세훈 |
2020 |
37529 |
Oncology |
Radium-223 in Asian patients with castration-resistant prostate cancer... |
ASIA-PAC J CLIN ONCO 2020 10.1111/ajco.13479 |
박세훈 |
2020 |
37528 |
Oncology |
Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients ... |
J CANCER 2020 10.7150/jca.48062 |
박세훈 |
2020 |
37527 |
Oncology |
Margetuximab plus pembrolizumab in patients with previously treated, H... |
LANCET ONCOL 2020 10.1016/S1470-2045(20)30326-0 |
박세훈 |
2020 |
37526 |
Oncology; Radiology, Nuclear Medicine & Medical Imaging |
Effect of baseline sarcopenia on adjuvant treatment for D2 dissected g... |
RADIOTHER ONCOL 2020 10.1016/j.radonc.2020.07.043 |
박세훈 |
2020 |
37525 |
Oncology |
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy ... |
LANCET ONCOL 2020 10.1016/S1470-2045(20)30541-6 |
박세훈 |
2020 |
37524 |
Oncology |
Clinical and molecular distinctions in patients with refractory colon ... |
THER ADV MED ONCOL 2020 10.1177/1758835920965842 |
박세훈 |
2020 |
37523 |
Medicine, General & Internal |
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Car... |
NEW ENGL J MED 2020 10.1056/NEJMoa2002788 |
박세훈 |
2020 |
37522 |
Oncology |
Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Out... |
CANCERS 2020 10.3390/cancers12123548 |
김석진 |
2020 |